FATE FATE THERAPEUTICS INC
Nasdaq · SEC CIK 1434316 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $322.8K 6 sales by 2 insiders
- Filings on record
- 170 since 2021-07-02, latest 2026-08-05 16:03
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Valamehr Bahram | Pres, CEO, Dir | — | $168.1K |
| TAHL CINDY | See Remarks | — | $154.7K |
| Adawi Kamal | CFO | — | — |
| Redmile Group, LLC | Dir, 10% | — | — |
| EPSTEIN ROBERT S | Dir | — | — |
| RASTETTER WILLIAM H | Dir | — | — |
Transactions 145
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 16:03 | 2026-08-04 | FATE | TAHL CINDY | See Remarks | S - Sale | $2.46 | -38.8K | 589.4K | -6% | -$95.4K | |
| 2026-08-05 16:01 | 2026-08-04 | FATE | Valamehr Bahram | Pres, CEO, Dir | S - Sale | $2.46 | -43.9K | 591.8K | -7% | -$108.1K | |
| 2026-05-21 16:02 | 2026-05-20 | FATE | TAHL CINDY | See Remarks | S - Sale | $1.88 | -25.6K | 628.2K | -4% | -$48.1K | |
| 2026-05-21 16:01 | 2026-05-20 | FATE | Valamehr Bahram | Pres, CEO, Dir | S - Sale | $1.88 | -28.9K | 635.8K | -4% | -$54.5K | |
| DM | 2026-05-07 16:00 | 2026-05-06 | FATE | TAHL CINDY | See Remarks | M - OptEx | $1.25 | +166.7K | 653.7K | +34% | +$208.0K |
| D | 2026-05-06 16:01 | 2026-05-05 | FATE | EPSTEIN ROBERT S | Dir | M - OptEx | $1.69 | +25.0K | 36.3K | +221% | +$42.2K |
| D | 2026-05-06 16:00 | 2026-05-05 | FATE | RASTETTER WILLIAM H | Dir | M - OptEx | $1.69 | +25.0K | 36.3K | +221% | +$42.2K |
| D | 2026-04-22 21:51 | 2026-04-20 | FATE | Redmile Group, LLC | Dir, 10% | J - Other | $0.00 | -8.98M | 0 | -100% | $0 |
| DI | 2026-04-22 21:51 | 2026-04-20 | FATE | Redmile Group, LLC | Dir, 10% | J - Other | $0.00 | +8.98M | 12.88M | +230% | $0 |
| D | 2026-01-16 | 2026-01-15 | FATE | Adawi Kamal | CFO | A - Grant | $0.00 | +25.0K | 100.0K | +33% | $0 |
| D | 2026-01-16 | 2026-01-15 | FATE | Valamehr Bahram | Pres, CEO, Dir | A - Grant | $0.00 | +335.0K | 664.7K | +102% | $0 |
| D | 2026-01-16 | 2026-01-15 | FATE | TAHL CINDY | See Remarks | A - Grant | $0.00 | +100.0K | 487.1K | +26% | $0 |
| 2026-01-12 | 2026-01-09 | FATE | Valamehr Bahram | Pres, CEO, Dir | S - Sale | $1.07 | -5,190 | 329.7K | -2% | -$5,553 | |
| 2026-01-12 | 2026-01-09 | FATE | TAHL CINDY | See Remarks | S - Sale | $1.06 | -10.6K | 387.1K | -3% | -$11.2K | |
| D | 2025-10-21 | 2025-10-20 | FATE | Adawi Kamal | CFO | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
| 2025-08-05 | 2025-08-04 | FATE | Valamehr Bahram | Pres, CEO, Dir | S - Sale | $1.06 | -14.5K | 334.9K | -4% | -$15.3K | |
| 2025-08-05 | 2025-08-04 | FATE | TAHL CINDY | See Remarks | S - Sale | $1.06 | -9,037 | 397.7K | -2% | -$9,579 | |
| D | 2025-01-16 | 2025-01-15 | FATE | Bressi Jerome Charles | See Remarks | A - Grant | $0.00 | +65.0K | 335.2K | +24% | $0 |
| D | 2025-01-16 | 2025-01-15 | FATE | TAHL CINDY | See Remarks | A - Grant | $0.00 | +70.0K | 406.7K | +21% | $0 |
| 2025-01-13 | 2025-01-10 | FATE | Valamehr Bahram | Pres, CEO, Dir | S - Sale | $1.54 | -8,705 | 349.4K | -2% | -$13.4K | |
| 2025-01-13 | 2025-01-10 | FATE | Bressi Jerome Charles | See Remarks | S - Sale | $1.55 | -5,980 | 270.2K | -2% | -$9,269 | |
| 2025-01-13 | 2025-01-10 | FATE | TAHL CINDY | See Remarks | S - Sale | $1.55 | -5,654 | 336.7K | -2% | -$8,764 | |
| DI | 2024-12-26 | 2024-12-20 | FATE | Green Jeremy | Dir, 10% | S - Sale | $1.68 | -341.6K | 12.49M | -3% | -$573.9K |
| DMI | 2024-12-26 | 2024-12-20 | FATE | Green Jeremy | Dir, 10% | J - Other | $1.68 | 0 | 11.74M | New | $0 |
| DI | 2024-12-26 | 2024-12-20 | FATE | Green Jeremy | Dir, 10% | P - Purchase | $1.68 | +398.0K | 12.88M | +3% | +$668.6K |
| DI | 2024-12-16 | 2024-12-12 | FATE | Green Jeremy | Dir, 10% | C - Cnv Deriv | — | +30.1K | 12.83M | +0.2% | — |
| T | 2024-08-07 | 2024-08-06 | FATE | Xu Yuan | Dir | S - Sale | $4.23 | -633 | 8,669 | -7% | -$2,678 |
| 2024-07-31 | 2024-07-29 | FATE | Valamehr Bahram | Chief R, D Off | A - Grant | $0.00 | +200.0K | 358.1K | +127% | $0 | |
| 2024-07-31 | 2024-07-29 | FATE | TAHL CINDY | GC, Sec | A - Grant | $0.00 | +200.0K | 342.4K | +140% | $0 | |
| T | 2024-03-05 | 2024-03-04 | FATE | Dulac Edward J III | CFO | S - Sale | $7.77 | -2,447 | 101.5K | -2% | -$19.0K |
| T | 2024-01-30 | 2024-01-29 | FATE | Dulac Edward J III | CFO | S - Sale | $5.00 | -1,849 | 103.9K | -2% | -$9,245 |
| 2024-01-10 | 2024-01-09 | FATE | Wolchko J Scott | Pres, CEO, Dir | S - Sale | $4.37 | -14.4K | 371.2K | -4% | -$62.9K | |
| 2024-01-10 | 2024-01-09 | FATE | Dulac Edward J III | CFO | S - Sale | $4.37 | -7,028 | 105.8K | -6% | -$30.7K | |
| 2024-01-10 | 2024-01-09 | FATE | Valamehr Bahram | Chief R, D Off | S - Sale | $4.38 | -11.3K | 158.1K | -7% | -$49.4K | |
| 2024-01-10 | 2024-01-09 | FATE | TAHL CINDY | GC, Sec | S - Sale | $4.37 | -10.9K | 142.4K | -7% | -$47.5K | |
| T | 2024-01-03 | 2024-01-02 | FATE | Dulac Edward J III | CFO | S - Sale | $3.66 | -5,182 | 112.8K | -4% | -$19.0K |
| I | 2023-12-28 | 2023-12-26 | FATE | Redmile Group, LLC | Dir, 10% | P - Purchase | $3.72 | +44.6K | 13.18M | +0.3% | +$166.0K |
| MI | 2023-12-28 | 2023-12-26 | FATE | Redmile Group, LLC | Dir, 10% | J - Other | $3.72 | 0 | 13.14M | New | $0 |
| 2023-12-19 | 2023-12-18 | FATE | Dulac Edward J III | CFO | S - Sale | $3.50 | -1,585 | 118.0K | -1% | -$5,548 | |
| 2023-11-13 | 2023-11-09 | FATE | TAHL CINDY | GC, Sec | S - Sale | $2.40 | -24.4K | 153.2K | -14% | -$58.5K | |
| 2023-08-21 | 2023-08-18 | FATE | Dulac Edward J III | CFO | S - Sale | $2.80 | -4,718 | 119.6K | -4% | -$13.2K | |
| 2023-08-07 | 2023-08-04 | FATE | Xu Yuan | Dir | S - Sale | $3.71 | -632 | 9,302 | -6% | -$2,345 | |
| 2023-07-06 | 2023-07-05 | FATE | Dulac Edward J III | CFO | S - Sale | $4.83 | -5,182 | 124.3K | -4% | -$25.0K | |
| 2023-07-06 | 2023-07-05 | FATE | Powl Brian T. | Chief Commercial Off | S - Sale | $4.87 | -3,854 | 41.1K | -9% | -$18.8K | |
| 2023-06-15 | 2023-06-14 | FATE | Xu Yuan | Dir | S - Sale | $5.58 | -3,460 | 9,934 | -26% | -$19.3K | |
| MI | 2023-04-21 | 2023-04-20+ | FATE | Green Jeremy | Dir, 10% | P - Purchase | $6.17 | +276.6K | 12.88M | +2% | +$1.71M |
| M | 2023-04-19 | 2023-04-18 | FATE | Chu Yu-Waye | Chief Medical Off | S - Sale | $6.57 | -2,532 | 140.7K | -2% | -$16.6K |
| DMI | 2023-04-17 | 2023-04-14 | FATE | Green Jeremy | Dir, 10% | J - Other | $5.84 | 0 | 12.83M | New | $0 |
| DI | 2023-04-17 | 2023-04-14 | FATE | Green Jeremy | Dir, 10% | P - Purchase | $6.00 | +25.7K | 12.86M | +0.2% | +$154.2K |
| DI | 2023-04-17 | 2023-04-14 | FATE | Green Jeremy | Dir, 10% | S - Sale | $5.84 | -302.3K | 12.83M | -2% | -$1.77M |
| DI | 2023-04-17 | 2023-04-13 | FATE | Green Jeremy | Dir, 10% | C - Cnv Deriv | — | +167.2K | 13.14M | +1% | — |
| D | 2023-01-20 | 2023-01-19 | FATE | MENDLEIN JOHN | Dir | M - OptEx | $1.37 | +28.5K | 311.2K | +10% | +$39.0K |
| M | 2023-01-13 | 2023-01-11+ | FATE | MENDLEIN JOHN | Dir | P - Purchase | $5.60 | +124.7K | 246.1K | +103% | +$698.1K |
| D | 2023-01-13 | 2023-01-12 | FATE | Valamehr Bahram | Chief R, D Off | M - OptEx | $1.37 | +423 | 169.3K | +0.3% | +$579.51 |
| 2023-01-11 | 2023-01-10 | FATE | Valamehr Bahram | Chief R, D Off | S - Sale | $5.24 | -10.9K | 168.9K | -6% | -$57.2K | |
| 2023-01-11 | 2023-01-10 | FATE | Plavsic Mark | Chief Technical Off | S - Sale | $5.24 | -3,418 | 123.7K | -3% | -$17.9K | |
| 2023-01-11 | 2023-01-10 | FATE | Wolchko J Scott | Pres, CEO, Dir | S - Sale | $5.24 | -45.9K | 385.6K | -11% | -$240.6K | |
| 2023-01-11 | 2023-01-10 | FATE | TAHL CINDY | GC, Sec | S - Sale | $5.24 | -11.6K | 177.6K | -6% | -$60.5K | |
| 2023-01-11 | 2023-01-10 | FATE | Dulac Edward J III | CFO | S - Sale | $5.24 | -7,331 | 129.5K | -5% | -$38.4K | |
| 2023-01-11 | 2023-01-10 | FATE | Chu Yu-Waye | Chief Medical Off | S - Sale | $5.24 | -7,825 | 143.2K | -5% | -$41.0K | |
| M | 2022-08-19 | 2022-08-18 | FATE | Dulac Edward J III | CFO | S - Sale | $29.81 | -5,135 | 137.2K | -4% | -$153.1K |
| DM | 2022-07-25 | 2022-07-21+ | FATE | Wolchko J Scott | Pres, CEO, Dir | S - Sale+OE | $32.74 | -36.2K | 434.9K | -8% | -$1.19M |
| DM | 2022-07-25 | 2022-07-21+ | FATE | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $2.70 | +36.2K | 437.8K | +9% | +$97.9K |
| D | 2022-07-08 | 2022-07-07 | FATE | Valamehr Bahram | Chief R, D Off | S - Sale+OE | $30.23 | -17.2K | 179.8K | -9% | -$518.7K |
| D | 2022-07-08 | 2022-07-07 | FATE | Valamehr Bahram | Chief R, D Off | M - OptEx | $2.73 | +17.2K | 197.0K | +10% | +$46.8K |
| D | 2022-07-07 | 2022-07-06 | FATE | Valamehr Bahram | Chief R, D Off | S - Sale+OE | $30.07 | -7,842 | 179.8K | -4% | -$235.8K |
| DM | 2022-07-07 | 2022-07-06 | FATE | Valamehr Bahram | Chief R, D Off | M - OptEx | $3.27 | +7,842 | 187.7K | +4% | +$25.6K |
| 2022-07-06 | 2022-07-05 | FATE | Plavsic Mark | Chief Technical Off | S - Sale | $24.61 | -3,719 | 127.1K | -3% | -$91.5K | |
| D | 2022-06-29 | 2022-06-27 | FATE | Powl Brian T. | Chief Commercial Off | A - Grant | $0.00 | +45.0K | 45.0K | New | $0 |
| D | 2022-06-13 | 2022-06-09 | FATE | RASTETTER WILLIAM H | Dir | A - Grant | $0.00 | +8,650 | 11.3K | +323% | $0 |
| D | 2022-06-13 | 2022-06-09 | FATE | Jooss Karin | Dir | A - Grant | $0.00 | +8,650 | 9,848 | +722% | $0 |
| D | 2022-06-13 | 2022-06-09 | FATE | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +8,650 | 10.7K | +431% | $0 |
| D | 2022-06-13 | 2022-06-09 | FATE | Xu Yuan | Dir | A - Grant | $0.00 | +8,650 | 13.4K | +182% | $0 |
| D | 2022-06-13 | 2022-06-09 | FATE | Agarwal Shefali | Dir | A - Grant | $0.00 | +8,650 | 10.5K | +470% | $0 |
| D | 2022-06-13 | 2022-06-09 | FATE | COUGHLIN TIMOTHY | Dir | A - Grant | $0.00 | +8,650 | 9,892 | +696% | $0 |
| D | 2022-06-13 | 2022-06-09 | FATE | EPSTEIN ROBERT S | Dir | A - Grant | $0.00 | +8,650 | 11.3K | +323% | $0 |
| D | 2022-06-13 | 2022-06-09 | FATE | MENDLEIN JOHN | Dir | A - Grant | $0.00 | +8,650 | 166.7K | +5% | $0 |
| DI | 2022-06-13 | 2022-06-09 | FATE | Redmile Group, LLC | Dir, 10% | A - Grant | $0.00 | +8,650 | 12.97M | +0.1% | $0 |
| D | 2022-06-13 | 2022-06-09 | FATE | Lee Michael Stewart | Dir | A - Grant | $0.00 | +8,650 | 11.3K | +323% | $0 |
| A | 2022-06-08 | 2022-06-03 | FATE | Agarwal Shefali | Dir | S - Sale | — | 0 | 2,681 | New | — |
| 2022-06-08 | 2022-06-07 | FATE | Agarwal Shefali | Dir | S - Sale | $21.89 | -841 | 1,840 | -31% | -$18.4K | |
| 2022-06-06 | 2022-06-03 | FATE | COUGHLIN TIMOTHY | Dir | S - Sale | $22.81 | -1,439 | 57.6K | -2% | -$32.8K | |
| 2022-06-06 | 2022-06-03 | FATE | MENDLEIN JOHN | Dir | S - Sale | $22.79 | -1,364 | 158.1K | -0.9% | -$31.1K | |
| 2022-06-06 | 2022-06-03 | FATE | HERSHBERG ROBERT | Dir | S - Sale | $22.75 | -672 | 2,009 | -25% | -$15.3K | |
| 2022-06-06 | 2022-06-03 | FATE | Jooss Karin | Dir | S - Sale | $22.82 | -1,483 | 1,198 | -55% | -$33.8K | |
| 2022-06-06 | 2022-06-03 | FATE | Agarwal Shefali | Dir | S - Sale | $22.80 | -807 | 1,874 | -30% | -$18.4K | |
| D | 2022-06-02 | 2022-06-01 | FATE | TAHL CINDY | GC, Sec | S - Sale+OE | $22.96 | -25.0K | 189.2K | -12% | -$574.0K |
| D | 2022-06-02 | 2022-06-01 | FATE | TAHL CINDY | GC, Sec | M - OptEx | $6.55 | +25.0K | 214.2K | +13% | +$163.8K |
| DM | 2022-04-25 | 2022-04-21+ | FATE | Wolchko J Scott | Pres, CEO, Dir | S - Sale+OE | $34.89 | -40.0K | 431.5K | -8% | -$1.40M |
| DM | 2022-04-25 | 2022-04-21+ | FATE | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $2.70 | +40.0K | 461.5K | +9% | +$108.0K |
| 2022-04-21 | 2022-04-19 | FATE | Chu Yu-Waye | Chief Medical Off | S - Sale | $35.37 | -4,062 | 151.0K | -3% | -$143.7K | |
| DM | 2022-04-04 | 2022-04-01 | FATE | TAHL CINDY | GC, Sec | M - OptEx | $5.22 | +25.0K | 214.2K | +13% | +$130.5K |
| D | 2022-04-04 | 2022-04-01 | FATE | TAHL CINDY | GC, Sec | S - Sale+OE | $38.85 | -25.0K | 189.2K | -12% | -$971.2K |
| D | 2022-03-15 | 2022-03-14 | FATE | Valamehr Bahram | Chief R, D Off | M - OptEx | $2.73 | +25.0K | 204.8K | +14% | +$68.2K |
| DM | 2022-03-15 | 2022-03-14 | FATE | Valamehr Bahram | Chief R, D Off | S - Sale+OE | $31.07 | -25.0K | 179.8K | -12% | -$776.7K |
| D | 2022-03-11 | 2022-03-10 | FATE | MENDLEIN JOHN | Dir | M - OptEx | $1.63 | +31.6K | 191.0K | +20% | +$51.4K |
| DM | 2022-03-11 | 2022-03-10 | FATE | MENDLEIN JOHN | Dir | S - Sale+OE | $35.02 | -31.6K | 171.5K | -16% | -$1.11M |
| DA | 2022-02-04 | 2022-01-20 | FATE | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $2.70 | +30.0K | 461.5K | +7% | +$81.0K |
| D | 2022-01-27 | 2022-01-25 | FATE | TAHL CINDY | See Remarks | A - Grant | $0.00 | +33.3K | 189.2K | +21% | $0 |
| D | 2022-01-27 | 2022-01-25 | FATE | Valamehr Bahram | See Remarks | A - Grant | $0.00 | +33.3K | 179.8K | +23% | $0 |
Purchase Sale Sale after option exercise All abbreviations